Site içinde arama yapın

Kajal Khomane bir ses eklendi Other
2026-03-25 07:43:14 - Translate -

Biosimilar Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
"Global Executive Summary Biosimilar Market: Size, Share, and Forecast The global biosimilar market size was valued at USD 64.93 billion in 2024 and is expected to reach USD 598.55 billion by 2032, at a CAGR of 32.00% during the forecast periodThe market expansion is primarily driven by the growing number of patent expiries of blockbuster biologics and the rising prevalence of chronic...

0 Yorumlar 0 hisse senetleri 397 Views 0 önizleme

Please log in to like, share and comment!
Kajal Khomane bir ses eklendi Other
2026-01-14 08:41:52 - Translate -

Biosimilar Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
"Regional Overview of Executive Summary Biosimilar Market by Size and Share The global biosimilar market size was valued at USD 64.93 billion in 2024 and is expected to reach USD 598.55 billion by 2032, at a CAGR of 32.00% during the forecast periodThe market expansion is primarily driven by the growing number of patent expiries of blockbuster biologics and the rising prevalence of...

0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme

Please log in to like, share and comment!
Dhepak Kumar bir ses eklendi Other
2026-02-18 06:19:36 - Translate -

Biosimilar Monoclonal Antibodies Market Future Business Opportunities and Market Sizing to 2033
Biosimilar Monoclonal Antibodies Industry Outlook: Straits Research has added a report titled “Global Biosimilar Monoclonal Antibodies Market Professional Report 2025-2033” to its database of research reports. The study provides complete details about the usage and adoption of Biosimilar Monoclonal Antibodies in various industrial applications and geographies. This helps the key...

0 Yorumlar 0 hisse senetleri 532 Views 0 önizleme

Please log in to like, share and comment!
Shrikant Pawar bir ses eklendi Other
2026-04-17 09:25:06 - Translate -

Biosimilar Monoclonal Antibody Market Analysis Shows Increasing Regulatory Approvals
The global biosimilar monoclonal antibody market is witnessing robust growth, driven by the increasing demand for cost-effective biologic therapies and the rising burden of chronic diseases such as cancer and autoimmune disorders. The market size was valued at USD 10.71 billion in 2024 and is projected to grow from USD 12.44 billion in 2025 to USD 40.77 billion...

0 Yorumlar 0 hisse senetleri 315 Views 0 önizleme

Please log in to like, share and comment!
Naznin Shaikh bir ses eklendi Crafts
2026-03-09 07:10:27 - Translate -

Biosimilars Market Forecast and Industry Outlook Through 2028
The biosimilars market is expected to continue expanding rapidly due to ongoing advancements in biotechnology and supportive regulatory frameworks. Increasing demand for affordable biologic therapies will remain a key driver. These factors indicate strong future growth for the global biosimilars industry. The global Biosimilars Market is experiencing remarkable growth as healthcare systems...

0 Yorumlar 0 hisse senetleri 5K Views 0 önizleme

Please log in to like, share and comment!
Naznin Shaikh bir ses eklendi Gardening
2026-03-09 07:09:00 - Translate -

Global Biosimilars Market Growth Driven by Rising Biologic Demand
The Biosimilars Market is experiencing rapid growth due to the increasing demand for cost-effective alternatives to biologic drugs. Healthcare systems across the world are adopting biosimilars to reduce treatment costs while maintaining similar therapeutic effectiveness. This growing acceptance is significantly supporting the expansion of the biosimilars industry. The global Biosimilars Market...

0 Yorumlar 0 hisse senetleri 4K Views 0 önizleme

Please log in to like, share and comment!
Rishika Datta bir ses eklendi Health
2026-03-18 05:00:51 - Translate -

Global Recombinant Human Insulin Market to Reach USD 9.7 Billion by 2034 Amid Rising Diabetes Burden
According to a new report from Intel Market Research, the global Recombinant Human Insulin market was valued at USD 5.8 billion in 2025 and is projected to reach USD 9.7 billion by 2034, growing at a CAGR of 5.6% during the forecast period (2026–2034). This sustained growth reflects the increasing global burden of diabetes and the shift toward biotechnology-derived insulin therapies that...

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme

Please log in to like, share and comment!
Rishika Datta bir ses eklendi Other
2026-03-13 10:10:59 - Translate -

VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology Therapies
According to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme

Please log in to like, share and comment!